Navigation Links
Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
Date:2/26/2008

ency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

Forward-Looking Statements

This announcement contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. For example, statements regarding the Company's financial position, business strategy and other plans and objectives for future operations, and assumptions and predictions about future product demand, supply, manufacturing, costs, marketing and pricing factors are all forward-looking statements. These statements are generally accompanied by words such as "intend," anticipate," "believe," "estimate," "potential(ly)," "continue," "forecast," "predict," "plan," "may," "will," "could," "would," "should," "expect" or the negative of such terms or other comparable terminology. The Company believes that the assumptions and expectations reflected in such forward-looking statements are reasonable, based on information available to it on the date hereof, but the Company cannot provide assurances that these assumptions and expectations will prove to have been correct or that the Company will take any action that the Company may presently be planning. However, these forward-looking statements are inherently subject to known and unknown risks and uncertainties. Actual results or experience may differ materially from those expected or anticipated in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, regulatory policies, available cash, research results, competition from other similar businesses, and market and general economic factors. This discussion should be read in conjunction with the conden
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Opportunities to Invest in Puerto Rico as Global Center for Biotechnology
2. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
3. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference to Webcast Millennium Presentation
5. Cardinal Health CEO of Clinical & Medical Products to Speak at Merrill Lynchs Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
9. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
10. BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Biotechnology Builds a New Heart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... 24/7 Care ... Angeles, Riverside, and San Bernardino, recently announced that the Centers for Medicare and Medicaid ... system of home health care providers. 24/7 Care At Home’s agency is one of ...
(Date:7/30/2015)... ... July 30, 2015 , ... OncLive®’s ... UCLA’s Jonsson Comprehensive Cancer Center (JCCC) mutually agreed to collaborate on ... OncLive’s editorial and marketing groups will help spread the news about the center’s ...
(Date:7/30/2015)... ... July 30, 2015 , ... Glidewell Laboratories, industry-leading ... of Inclusive™ magazine, its multimedia publication focused on implant dentistry, is now available ... issue, Volume 6, Issue 2, as well as past issues of the dental ...
(Date:7/30/2015)... FL (PRWEB) , ... July 30, 2015 , ... On ... than $2 billion in taxpayer money to fund the state’s large prison system, which ... country with the highest rates of incarceration. In light of President Obama’s recent reduction ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Gummy ... including lip lowering, gum contouring and surgery, as well as the patented gum depigmentation ... that has made him popular with many patients from around the world. , “Like ...
Breaking Medicine News(10 mins):Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 3Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 4Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 4Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2
... In its efforts to promote Kerala as an ideal destination for ... in the US, Britain, Dubai, Muscat, Kuwait, Sri Lanka and the ... it has to be systematic and we have asked the CII ... the policy and when we announce it shortly we would become ...
... outbreak in the Sydney CBD is linked to the Royal ... suspect//. However, they could not confirm the link. ... bacteria belonging to the Legionella family, Legionella pneumophilia, have been ... in the Circular Quay area on New Year's Eve. ...
... University and pediatric specialists at Baylor College of Medicine have ... as passkeys that allows drugs to enter cancer cells. ... of the journal Organic and Biomolecular Chemistry. ,All ... Cell walls, or membranes, form a protective cocoon around the ...
... Hopkins Researchers have shown that a drug commonly used ... engineered mice with Marfan syndrome and also prevents muscle ... ,The results are reported online this week at Nature ... Harry "Hal" Dietz, M.D., discovered that treating Marfan mice ...
... took more control over choosing their breast cancer surgeon were ... surgeons and at a hospital affiliated with an accredited cancer ... or their health plan, according to a study led by ... ,The study looked at 1,844 women recently diagnosed with ...
... to have a beneficial effect on the health of men. Some ... the following // ,Vegetables like tomatoes, carrot, garlic and whole ... like oysters, shrimps and deep sea fish has the similar effect ... and nutrients and also help in secretion of gastric acid. The ...
Cached Medicine News:Health News:Buckyballs Used as 'Passkey' into Cancer Cells 2Health News:Common BP Drug Treats Muscular Dystrophy 2Health News:Common BP Drug Treats Muscular Dystrophy 3Health News:Are Women Seeing the Most Experienced Breast Cancer Surgeons? 2
(Date:7/29/2015)... , July 30, ... Guidance   ... including Core Earnings and ... Highlights of Q1 results  ... Underlying core earnings and underlying core EPS were flat, year-to-year , ...
(Date:7/29/2015)... Pa. , July 29, 2015  Unilife Corporation ... ASX: UNS), a developer, manufacturer and supplier of injectable ... multifaceted financing strategy that provides the Company with flexibility ... Unilife has signed an equity purchase agreement ... Fund, LLC ("LPC"), a Chicago -based ...
(Date:7/29/2015)... , July 29, 2015  Ascendis Pharma A/S ... that applies its innovative TransCon technology to address significant ... a conference call on July 30, 2015, at 9:00 ... a Phase 2 pediatric study of once-weekly TransCon Growth ... the top-line results before the market opens on July ...
Breaking Medicine Technology:Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 2Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 4Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 5Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5Ascendis Pharma A/S to Report Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone and Host Conference Call on Thursday, July 30, 2015 at 9:00 a.m. Eastern Time 2
... Kanghui Holdings (NYSE: KH ) ("Kanghui" or ... of orthopedic implants in China, today announced that all ... meeting held in Hong Kong on September 5, 2011 ... , Re-election of Mr. Yikang Jiang as a ...
... Discovery Labs, Inc. (Nasdaq: DSCO ) today ... Complete Response to the 2009 Complete Response Letter issued by ... (lucinactant) for the prevention of respiratory distress syndrome (RDS) ... will designate the Complete Response as a Class 2 ...
Cached Medicine Technology:China Kanghui Holdings Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting 2Discovery Labs Submits SURFAXIN® Complete Response to FDA 2Discovery Labs Submits SURFAXIN® Complete Response to FDA 3Discovery Labs Submits SURFAXIN® Complete Response to FDA 4
... Finntip Filters are ideal ... methods, or for any work ... They are designed for pipetting ... samples, and other. For applications ...
Inquire...
... Aerosol barrier tips eliminate false ... Scientifically designed and tested, Promega Barrier ... working with amplified nucleic acids (PCR(a)), ... samples, forensic and serological specimens. , ...
... tips eliminate false signals and contamination ... tested, Promega Barrier Tips offer performance ... nucleic acids (PCR(a)), radioactive isotopes, tissue ... serological specimens. , ,Promega Barrier Tips ...
Medicine Products: